Selected research
Industry Research
Sertraline Industry Research Report 2026
Market perspective
The global Sertraline market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Sertraline is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Sertraline is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Sertraline is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Sertraline include Teva, Sun Pharmaceutical, Mylan, Pfizer, Torrent Pharmaceuticals, Oxford Pharma, Neurocon Inc, Lupin Pharmaceuticals and Lifecare Neuro, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Sertraline market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Sertraline Market by Company
Teva
Sun Pharmaceutical
Mylan
Pfizer
Torrent Pharmaceuticals
Oxford Pharma
Neurocon Inc
Lupin Pharmaceuticals
Lifecare Neuro
Healing Pharma India Pvt Ltd
Camber Pharmaceuticals
Aurobindo Pharma
APOTEX
Sertraline Segment by Type
Tablet
Oral Concentrate
Sertraline Segment by Application
Adult
Children
Sertraline Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sertraline market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sertraline and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sertraline.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Sertraline manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Sertraline by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Sertraline in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Oral Concentrate
Applications
- Adult
- Children
Companies covered
- Teva
- Sun Pharmaceutical
- Mylan
- Pfizer
- Torrent Pharmaceuticals
- Oxford Pharma
- Neurocon Inc
- Lupin Pharmaceuticals
- Lifecare Neuro
- Healing Pharma India Pvt Ltd
- Camber Pharmaceuticals
- Aurobindo Pharma
- APOTEX
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Sertraline Market Size (2021-2032)
- 2.2.2 Global Sertraline Sales (2021-2032)
- 2.2.3 Global Sertraline Market Average Price (2021-2032)
- 2.3 Sertraline by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablet
- 2.3.3 Oral Concentrate
- 2.4 Sertraline by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Adult
- 2.4.3 Children
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Sertraline Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Sertraline Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Sertraline Revenue of Manufacturers (2021-2026)
- 3.4 Global Sertraline Average Price by Manufacturers (2021-2026)
- 3.5 Global Sertraline Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Sertraline, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Sertraline, Product Type & Application
- 3.8 Global Manufacturers of Sertraline, Established Date
- 3.9 Global Sertraline Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Sertraline Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Sertraline Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 Sun Pharmaceutical
- 4.2.1 Sun Pharmaceutical Company Information
- 4.2.2 Sun Pharmaceutical Business Overview
- 4.2.3 Sun Pharmaceutical Sertraline Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sun Pharmaceutical Sertraline Product Portfolio
- 4.2.5 Sun Pharmaceutical Recent Developments
- 4.3 Mylan
- 4.3.1 Mylan Company Information
- 4.3.2 Mylan Business Overview
- 4.3.3 Mylan Sertraline Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Mylan Sertraline Product Portfolio
- 4.3.5 Mylan Recent Developments
- 4.4 Pfizer
- 4.4.1 Pfizer Company Information
- 4.4.2 Pfizer Business Overview
- 4.4.3 Pfizer Sertraline Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pfizer Sertraline Product Portfolio
- 4.4.5 Pfizer Recent Developments
- 4.5 Torrent Pharmaceuticals
- 4.5.1 Torrent Pharmaceuticals Company Information
- 4.5.2 Torrent Pharmaceuticals Business Overview
- 4.5.3 Torrent Pharmaceuticals Sertraline Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Torrent Pharmaceuticals Sertraline Product Portfolio
- 4.5.5 Torrent Pharmaceuticals Recent Developments
- 4.6 Oxford Pharma
- 4.6.1 Oxford Pharma Company Information
- 4.6.2 Oxford Pharma Business Overview
- 4.6.3 Oxford Pharma Sertraline Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Oxford Pharma Sertraline Product Portfolio
- 4.6.5 Oxford Pharma Recent Developments
- 4.7 Neurocon Inc
- 4.7.1 Neurocon Inc Company Information
- 4.7.2 Neurocon Inc Business Overview
- 4.7.3 Neurocon Inc Sertraline Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Neurocon Inc Sertraline Product Portfolio
- 4.7.5 Neurocon Inc Recent Developments
- 4.8 Lupin Pharmaceuticals
- 4.8.1 Lupin Pharmaceuticals Company Information
- 4.8.2 Lupin Pharmaceuticals Business Overview
- 4.8.3 Lupin Pharmaceuticals Sertraline Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Lupin Pharmaceuticals Sertraline Product Portfolio
- 4.8.5 Lupin Pharmaceuticals Recent Developments
- 4.9 Lifecare Neuro
- 4.9.1 Lifecare Neuro Company Information
- 4.9.2 Lifecare Neuro Business Overview
- 4.9.3 Lifecare Neuro Sertraline Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Lifecare Neuro Sertraline Product Portfolio
- 4.9.5 Lifecare Neuro Recent Developments
- 4.10 Healing Pharma India Pvt Ltd
- 4.10.1 Healing Pharma India Pvt Ltd Company Information
- 4.10.2 Healing Pharma India Pvt Ltd Business Overview
- 4.10.3 Healing Pharma India Pvt Ltd Sertraline Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Healing Pharma India Pvt Ltd Sertraline Product Portfolio
- 4.10.5 Healing Pharma India Pvt Ltd Recent Developments
- 4.11 Camber Pharmaceuticals
- 4.11.1 Camber Pharmaceuticals Company Information
- 4.11.2 Camber Pharmaceuticals Business Overview
- 4.11.3 Camber Pharmaceuticals Sertraline Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Camber Pharmaceuticals Sertraline Product Portfolio
- 4.11.5 Camber Pharmaceuticals Recent Developments
- 4.12 Aurobindo Pharma
- 4.12.1 Aurobindo Pharma Company Information
- 4.12.2 Aurobindo Pharma Business Overview
- 4.12.3 Aurobindo Pharma Sertraline Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Aurobindo Pharma Sertraline Product Portfolio
- 4.12.5 Aurobindo Pharma Recent Developments
- 4.13 APOTEX
- 4.13.1 APOTEX Company Information
- 4.13.2 APOTEX Business Overview
- 4.13.3 APOTEX Sertraline Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 APOTEX Sertraline Product Portfolio
- 4.13.5 APOTEX Recent Developments
5 Global Sertraline Market Scenario by Region
- 5.1 Global Sertraline Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Sertraline Sales by Region: 2021-2032
- 5.2.1 Global Sertraline Sales by Region: 2021-2026
- 5.2.2 Global Sertraline Sales by Region: 2027-2032
- 5.3 Global Sertraline Revenue by Region: 2021-2032
- 5.3.1 Global Sertraline Revenue by Region: 2021-2026
- 5.3.2 Global Sertraline Revenue by Region: 2027-2032
- 5.4 North America Sertraline Market Facts & Figures by Country
- 5.4.1 North America Sertraline Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Sertraline Sales by Country (2021-2032)
- 5.4.3 North America Sertraline Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Sertraline Market Facts & Figures by Country
- 5.5.1 Europe Sertraline Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Sertraline Sales by Country (2021-2032)
- 5.5.3 Europe Sertraline Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Sertraline Market Facts & Figures by Country
- 5.6.1 Asia Pacific Sertraline Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Sertraline Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Sertraline Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Sertraline Market Facts & Figures by Country
- 5.7.1 South America Sertraline Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Sertraline Sales by Country (2021-2032)
- 5.7.3 South America Sertraline Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Sertraline Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Sertraline Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Sertraline Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Sertraline Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Sertraline Sales by Type (2021-2032)
- 6.1.1 Global Sertraline Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Sertraline Sales Market Share by Type (2021-2032)
- 6.2 Global Sertraline Revenue by Type (2021-2032)
- 6.2.1 Global Sertraline Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Sertraline Revenue Market Share by Type (2021-2032)
- 6.3 Global Sertraline Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Sertraline Sales by Application (2021-2032)
- 7.1.1 Global Sertraline Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Sertraline Sales Market Share by Application (2021-2032)
- 7.2 Global Sertraline Revenue by Application (2021-2032)
- 7.2.1 Global Sertraline Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Sertraline Revenue Market Share by Application (2021-2032)
- 7.3 Global Sertraline Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Sertraline Value Chain Analysis
- 8.1.1 Sertraline Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Sertraline Production Mode & Process
- 8.2 Sertraline Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Sertraline Distributors
- 8.2.3 Sertraline Customers
9 Global Sertraline Analyzing Market Dynamics
- 9.1 Sertraline Industry Trends
- 9.2 Sertraline Industry Drivers
- 9.3 Sertraline Industry Opportunities and Challenges
- 9.4 Sertraline Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst